Patents Assigned to Encompass Development, Inc.
  • Patent number: 10821092
    Abstract: Compositions and methods for providing anesthesia to the eye, for treating or preventing inflammatory disorders in the eye, or for treating or preventing ocular infections, are disclosed. The compositions include a glycosaminoglycan, such as hyaluronic acid, in a concentration suitable for achieving a desired viscosity, as well as an active agent, such as an anesthetic, anti-inflammatory, antimicrobial, antiproliferative, antimetabolite, prostaglandin, antioxidant, TGF-beta, or mitomycin C.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: November 3, 2020
    Assignee: Encompass Development, Inc.
    Inventors: Thomas Rowe, Richard Coulon